Table 2.
n, UV patients per year |
P-value | ||
---|---|---|---|
Median | IQR | ||
Region of residence | |||
NA (n = 163) | 2 | 1–4 | <0.001 |
LA (n = 163) | 5 | 2–10 | |
EU (n = 399) | 5 | 2–10 | |
AME (n = 34) | 5 | 3–16 | |
AP (n = 106) | 5 | 2–10 | |
Specialtya | |||
Dermatology (n = 153) | 5 | 3–13 | <0.001 |
Allergy (n = 535) | 4 | 2–10 | |
Pediatrics (n = 20) | 2 | 1–4 | |
Place of worka | |||
University clinic (n = 223) | 5 | 2–10 | <0.001 |
Hospital (n = 159) | 4 | 2–7 | |
Private practice (n = 245) | 3 | 1–6 |
Respondents who fitted in two and more groups, e.g. had two specialties, were not included in the analysis; IQR: interquartile range; NA: North America; LA: Latin America; EU: Europe; AME: Africa/Middle-East; AP: Asia-Pacific